Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 7A2, mitochondrial (COX7A2), is a nuclear-encoded structural subunit of complex IV (cytochrome c oxidase) of the mitochondrial respiratory chain[2][3]. Complex IV catalyzes electron transfer from cytochrome c to molecular oxygen and contributes to the proton gradient that drives ATP synthesis via oxidative phosphorylation in mitochondria[2][3]. COX7A2 is widely expressed in both muscle and non-muscle tissues and is distinct from the muscle-specific isoform COX7A1[3][4]. This subunit is thought to play a regulatory and assembly role within complex IV rather than contributing catalytically to electron transfer. Variants and dysregulation of COX7A2 or its complex can be associated with mitochondrial diseases and have been linked to some cancer types as a component of altered mitochondrial function[3]. COX7A2 is not currently recognized as a direct drug target or clinical biomarker, and its effects are understood in the context of the integrity and function of the mitochondrial electron transport chain[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 7A2, mitochondrial (COX7A2).